Search for: "DOW PHARMACEUTICAL SCIENCES, INC."
Results 121 - 130
of 130
Sort by Relevance
|
Sort by Date
28 Apr 2008, 6:06 am
Merrell Dow Pharmaceuticals, Inc. [read post]
10 Mar 2008, 1:10 pm
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993); General Electric Co. v. [read post]
7 Feb 2008, 10:46 am
In addition, the resolution of any regulatory violation issue needs to be documented with explicit correspondence from the FDA (letters or preserved emails) that any violation has been addressed and cured to the satisfaction of the Agency.None of this is rocket science. [read post]
5 Nov 2007, 12:58 pm
Merrell Dow Pharmaceuticals, Inc., 43 F.3d 1311, 1320 (9th Cir. 1995); DeLuca v. [read post]
30 Oct 2007, 11:28 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), to challenge the reliability of that testimony. [read post]
4 Oct 2007, 8:10 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), in which the Supreme Court first tried to evict "junk science," at least from the federal courts. [read post]
5 Sep 2007, 7:39 am
There, the defendant pharmaceutical manufacturer, Merck, produced over two million documents and withheld roughly 30,000 documents (or about 500,000 pages) based on attorney-client privilege or work product claims. [read post]
27 Apr 2007, 12:04 pm
Amgen itself pours out $ 3.4 billion in research costs each year, 90 % of which advances science but represents false starts in terms of any commercial possibilities. [read post]
12 Apr 2007, 1:33 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 592 (1993). [read post]
18 Jan 2007, 10:48 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993). [read post]
